Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer
Open Access
- 4 November 2010
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (19) , 1822-1832
- https://doi.org/10.1056/nejmsa0910784
Abstract
The Medicare Modernization Act led to moderate reductions in reimbursement for androgen-deprivation therapy (ADT) for prostate cancer, starting in 2004 and followed by substantial changes in 2005. We hypothesized that these reductions would lead to decreases in the use of ADT for indications that were not evidence based.Keywords
This publication has 22 references indexed in Scilit:
- Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare populationCancer, 2008
- Characteristics of Urologists Predict the Use of Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2007
- Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinomaCancer, 2005
- 6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate CancerJAMA, 2004
- Critical evaluation of hormonal therapy for carcinoma of the prostateUrology, 2002
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialThe Lancet, 2002
- COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, 1998
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989